ER Capital risk profile
85 Acute at or past the historical limit
Measured 5 September 2026 from ERC.AS's filed statements. Recomputed nightly.
85 (Acute), driven by Cash conversion at 100, over 4 weighted categories on the GENERAL profile.
What is measured
| Mechanism | Reading | Band | Direction | Driver |
|---|---|---|---|---|
| Market expectation | 72 | Stretched | No prior period | Drawdown from the 52-week high — 40.5% |
| Operating pressure | 69 | Stretched | No prior period | Costs outgrowing revenue — +43.0 percentage points |
| Cash conversion | 100 | Acute | Stable | Capital spending against operating cash — -0.04x |
| Leverage and coverage | 100 | Acute | Worsening | Net debt to EBITDA |
| Competitive position | Reads research_and_development, operating_income, revenue, peer cohort and disclosed transition KPIs. No reading is stored for this company. | |||
| Concentration | Reads identified supplier spend, customers above the 10% disclosure threshold and revenue by region. No reading is stored for this company. | |||
These are descriptive readings of disclosed mechanisms, not investment advice, and not a prediction. A band says where a measured input sits, never what to do about it or what happens next.